E20 Capital’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
E20 Capital's TXG Position: Q3 2026 in Review
E20 Capital opened a new position in 10x Genomics (TXG) in Q3 2026: 198,409 shares worth $17.9M. The stake represents 1.48% of the portfolio and ranks #14 among its holdings.
482 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- E20 Capital held 198,409 shares of 10x Genomics worth $17.9M as of Q3 2026.
- 10x Genomics was a new E20 Capital position in Q3 2026.
- 10x Genomics made up 1.48% of E20 Capital's portfolio in Q3 2026, its #14 holding.
- 482 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on E20 Capital's 13F filing for Q3 2026, filed 13 Nov 2026.